Analysis of PTEN/MMAC1 alteration in neuroblastoma

Altura, 1997, Novel regions of chromosomal loss in familial neuroblastoma by comparative genomic hybridization, Genes Chromosom Cancer, 19, 176, 10.1002/(SICI)1098-2264(199707)19:3<176::AID-GCC7>3.0.CO;2-V Takita, 1995, Allelotype of neuroblastoma, Oncogene, 11, 1829 White, 1995, Enomoto H, Sakiyama S, Brodeur GM. A region of consistent deletion in neuroblastoma maps within human chromosome 1p36.2–36.3, Proc Natl Acad Sci USA, 92, 5520, 10.1073/pnas.92.12.5520 Kaneko, 1987, Different karyotypic patterns in early and advanced stage neuroblastomas, Cancer Res, 47, 311 Li, 1997, PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer, Science, 275, 1943, 10.1126/science.275.5308.1943 Steck, 1997, Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers, Nat Genet, 15, 356, 10.1038/ng0497-356 Stambolic, 1998, Negative regulation of PKB/AKT-dependent cell survival by the tumor suppressor PTEN, Cell, 95, 29, 10.1016/S0092-8674(00)81780-8 Wang, 1997, Somatic mutations of PTEN in glioblastoma multiforme, Cancer Res, 57, 4183 Guldberg, 1997, Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma, Cancer Res, 57, 3660 Rhei, 1997, Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in primary breast carcinomas, Cancer Res, 57, 3657 Cairns, 1997, Frequent inactivation of PTEN/MMAC1 in primary prostate cancer, Cancer Res, 57, 4997 Dracopoli, 1989, Loss of alleles from the distal short arm of chromosome 1 occurs late in melanoma tumor progression, Proc Natl Acad Sci USA, 86, 4614, 10.1073/pnas.86.12.4614 Sugimoto, 1986, Identical expression of cell surface membrane antigens on two parent and eighteen cloned cell lines derived from two different neuroblastoma metastases of the same patient, Cancer Res, 46, 4765 Sugimoto, 1989, Differential susceptibility of HLA class II antigens induced by γ-Interferon in human neuroblastoma cell lines, Cancer Res, 49, 1824 Kuroda, 1991, Different drug sensitivity in two neuroblastoma cell lines established from the same patient before and after chemotherapy, Int J Cancer, 47, 732, 10.1002/ijc.2910470518 Reynolds, 1986, Characterization of human neuroblastoma cell lines established before and after therapy, J Natl Cancer Inst, 76, 375 Brodeur, 1993, Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment, J Clin Oncol, 11, 1466, 10.1200/JCO.1993.11.8.1466 Suzuki, 1998, Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues, Cancer Res, 58, 204 Gyapay, 1994, The 1933–1944 Genethon human genetic linkage map, Nat Genet, 7, 246, 10.1038/ng0694supp-246 Lo Sh, 1994, Tensin, Bioessays, 16, 817, 10.1002/bies.950161108 Ungewickell, 1995, Role of auxilin in uncoating clathrin-coated vesicles, Nature, 378, 632, 10.1038/378632a0 Ali, 1999, Mutational spectra of PTEN/MMAC1 gene, J Natl Cancer Inst, 91, 1922, 10.1093/jnci/91.22.1922 Georgescu, 1999, The tumor-suppressor activity of PTEN is regulated by its carboxyl-terminal region, Proc Natl Acad Sci USA, 96, 10182, 10.1073/pnas.96.18.10182 Chi, 1998, Mutational abrogation of the PTEN/MMAC1 gene in gastrointestinal polyps in patients with Cowden disease, Gastroenterology, 115, 1084, 10.1016/S0016-5085(98)70078-2 Whang, 1998, Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression, Proc Natl Acad Sci USA, 95, 5246, 10.1073/pnas.95.9.5246